<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:DCPH (USA) Also Trade In: Germany

Deciphera Pharmaceuticals Inc $ 34.43 1.27 (3.83%)

Volume:
199,242
Avg Vol (1m):
782,541
Market Cap $:
1.74 Bil
Enterprise Value $:
1.52 Bil
P/E (TTM):
0.00
P/B:
5.93
Warning! GuruFocus has detected 2 Medium warning signs with DCPH. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

7.8/10
Current Vs Industry Vs History
Cash-To-Debt 134.34
Equity-to-Asset 0.86
N/A
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
N/A
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 27.32
DISTRESS
GREY
SAFE

Profitability

4/10
Current Vs Industry Vs History
Operating Margin % -526.88
Net Margin % -502.31
ROE % -45.39
ROA % -40.27
ROC (Joel Greenblatt) % -1136.77
3-Year EBITDA Growth Rate -49.6
N/A
3-Year EPS without NRI Growth Rate -43.8
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 5.93
PS Ratio 52.68
EV-to-EBIT -12.1
N/A
EV-to-EBITDA -12.15
N/A
EV-to-Revenue 60.8
N/A
Current Ratio 7.26
Quick Ratio 7.26
Days Sales Outstanding 292

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.2
N/A

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 5.9
Price-to-Median-PS-Value 1.47
Earnings Yield (Greenblatt) % -8.27